Gene · 7170
Papers3,595
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
941 to 960 of 3,595
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genomic and transcriptomic characterization of heterogeneous immune subgroups of microsatellite instability-high colorectal cancers. | J Immunother Cancer | 2021 | 34903553 | PubTator, text mining | PubMed |
| The prognostic and clinical significance of IFI44L aberrant downregulation in patients with oral squamous cell carcinoma. | BMC Cancer | 2021 | 34903206 | PubTator, text mining | PubMed |
| Identification of a Novel Delta Opioid Receptor Agonist Chemotype with Potential Negative Allosteric Modulator Capabilities. | Molecules | 2021 | 34885825 | PubTator, text mining | PubMed |
| Proteomic Signatures of Diffuse and Intestinal Subtypes of Gastric Cancer. | Cancers (Basel) | 2021 | 34885041 | PubTator, text mining | PubMed |
| Deepening the Knowledge of ROS1 Rearrangements in Non-Small Cell Lung Cancer: Diagnosis, Treatment, Resistance and Concomitant Alterations. | Int J Mol Sci | 2021 | 34884672 | PubTator, text mining | PubMed |
| Cytoplasmic dynein-1 cargo diversity is mediated by the combinatorial assembly of FTS-Hook-FHIP complexes. | Elife | 2021 | 34882091 | PubTator, text mining | PubMed |
| Molecular basis for redox control by the human cystine/glutamate antiporter system xc. | Nat Commun | 2021 | 34880232 | PubTator, text mining | PubMed |
| Isoliquiritigenin, a potent human monoamine oxidase inhibitor, modulates dopamine D1, D3, and vasopressin V1A receptors. | Sci Rep | 2021 | 34876600 | PubTator, text mining | PubMed |
| Coordination of -1 programmed ribosomal frameshifting by transcript and nascent chain features revealed by deep mutational scanning. | Nucleic Acids Res | 2021 | 34871407 | PubTator, text mining | PubMed |
| The Significance of RHD Genotyping and Characteristic Analysis in Chinese RhD Variant Individuals. | Front Immunol | 2021 | 34867989 | PubTator, text mining | PubMed |
| Gating and Regulatory Mechanisms of TMEM16 Ion Channels and Scramblases. | Front Physiol | 2021 | 34867487 | PubTator, text mining | PubMed |
| Case Report: Unusual Clinical Presentation of a Rare Cardiac Inflammatory Myofibroblastic Tumor in Children: The Differential Diagnosis With Pediatric Emergencies. | Front Pediatr | 2021 | 34858900 | PubTator, text mining | PubMed |
| Identification and characterization of an atypical Gαs-biased β2AR agonist that fails to evoke airway smooth muscle cell tachyphylaxis. | Proc Natl Acad Sci U S A | 2021 | 34857633 | PubTator, text mining | PubMed |
| Functional enrichment of alternative splicing events with NEASE reveals insights into tissue identity and diseases. | Genome Biol | 2021 | 34857024 | PubTator, text mining | PubMed |
| Cell cycle regulation of ER membrane biogenesis protects against chromosome missegregation. | Dev Cell | 2021 | 34852214 | PubTator, text mining | PubMed |
| Structure based prediction of a novel GPR120 antagonist based on pharmacophore screening and molecular dynamics simulations. | Comput Struct Biotechnol J | 2021 | 34849208 | PubTator, text mining | PubMed |
| Molecular targeted therapy for advanced or metastatic soft tissue sarcoma. | Cancer Control | 2021 | 34844463 | PubTator, text mining | PubMed |
| Structural Effects of Disease-Related Mutations in Actin-Binding Period 3 of Tropomyosin. | Molecules | 2021 | 34834072 | PubTator, text mining | PubMed |
| Co-Evolution of Opioid and Adrenergic Ligands and Receptors: Shared, Complementary Modules Explain Evolution of Functional Interactions and Suggest Novel Engineering Possibilities. | Life (Basel) | 2021 | 34833093 | PubTator, text mining | PubMed |
| NTRK Gene Fusion Detection in Atypical Spitz Tumors. | Int J Mol Sci | 2021 | 34830218 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7170/papers?page=48